drugset / Trial / NCT00703573
A Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 2 Doses of S-777469 in Patients With Atopic Dermatitis
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the safety and efficacy of 2 doses of S-777469 in patients with atopic dermatitis.
Timeline
- Start
- 2008-05
- Primary completion
- 2009-05
- Completion
- 2009-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | S-777469 | Small molecule | 400 mg | — |
| Subject | S-777469 | Small molecule | 800 mg | — |